Paysign Q3 revenue beats on patient affordability programs
Overview
U.S. patient affordability and plasma payments firm's Q3 2026 revenue rose 43%, beating analyst expectations
Gross margin expanded to 64.7%, driven by growth in patient affordability programs
Company raised full-year guidance for gross margin, net income, EPS, and adjusted EBITDA
Outlook
Paysign sees 2026 revenue at $114.0 mln to $117.0 mln
Company raises 2026 guidance for gross margin, net income, GAAP EPS and adjusted EBITDA
Paysign expects to exit 2026 with 190-195 patient affordability programs and 445-450 plasma centers
Result Drivers
PATIENT AFFORDABILITY GROWTH - Co said revenue surge was driven by expansion of patient affordability programs and higher revenue per program
MIX SHIFT - Higher share of pharma revenue contributed to margin expansion
PLASMA UTILIZATION - Higher average revenue per plasma center offset impact of declining center count
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Beat | $30.80 mln | $29.02 mln (5 Analysts) |
Q3 Net Income | $6.74 mln | ||
Q3 Gross Margin | 64.70% |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the business support services peer group is "buy"
Wall Street's median 12-month price target for Paysign Inc is $15.00, about 2.1% above its November 6 closing price of $14.69
The stock recently traded at 36 times the next 12-month earnings vs. a P/E of 32 three months ago
Reuters Recommended Reads
Nov 9 - Lincoln Educational Q3 revenue rises 13%, beats estimates
Nov 9 - Israel's Kamada Q3 revenue up 11%, raises forecast
Nov 9 - Biopharma Almirall 9M sales rise on European dermatology growth
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)